| Terminated | Study of Pembrolizumab and Concurrent Radiation in Patients With Previously Treated Carcinoma of Unknown Prima Carcinoma, Unspecified Site | Phase 2 | 2018-02-01 |
| Completed | Study of Pembrolizumab in Combination With Chemotherapy for Patients With Advanced Colorectal Cancer Colorectal Cancer | Phase 2 | 2015-05-28 |
| Withdrawn | BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients Ovarian Cancer | Phase 1 / Phase 2 | 2012-10-01 |
| Completed | First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial Carcinoma Urothelial Carcinoma | Phase 2 | 2012-01-01 |
| Terminated | Doxorubicin + BIBF 1120 in Patients for Ovarian Cancer Ovarian Cancer | Phase 1 | 2011-11-01 |
| Terminated | Fludarabine, Velcade and Rituximab for Relapsed or Refractory Follicular Non-Hodgkin Lymphoma Lymphoma, Non-Hodgkin | Phase 2 | 2010-10-01 |
| Withdrawn | Second-Line Docetaxel + ASA404 for Advanced Urothelial Carcinoma Urothelial Carcinoma | Phase 2 | 2010-06-01 |
| Completed | PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations Breast Cancer | Phase 2 | 2010-02-01 |
| Completed | BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell C Renal Cell Carcinoma | Phase 1 / Phase 2 | 2010-01-01 |
| Terminated | Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer Breast Cancer | — | 2009-08-01 |
| Terminated | Pemetrexed and Radiation for Poor-Risk Stage III Non-Small Cell Lung Cancer Non-Small Cell Lung Cancer | Phase 2 | 2009-01-01 |
| Completed | Sutent + Taxol for Advanced Esophageal Cancer Esophageal Cancer | Phase 2 | 2008-08-01 |
| Completed | Neoadjuvant Dasatinib and Radical Cystectomy for Transitional Cell Carcinoma of the Bladder Transitional Cell Carcinoma of the Bladder | N/A | 2008-06-01 |
| Completed | Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer Small Cell Lung Cancer | Phase 2 | 2008-01-01 |
| Completed | Aprepitant + a 5HT3 + Dexamethasone in Patients With Germ Cell Tumors Germ Cell Tumors | Phase 3 | 2007-12-01 |
| Terminated | A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer Metastatic Breast Cancer | Phase 2 | 2007-10-01 |
| Terminated | Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer Breast Cancer | — | 2007-09-01 |
| Completed | Phase I/Randomized Phase II Study of Second Line Therapy With Irinotecan + Cetuximab +/- RAD001 for Colorectal Colorectal Cancer | Phase 1 / Phase 2 | 2007-08-01 |
| Completed | A Biological Sample Collection Protocol of Women With and Without Breast Cancer Breast Cancer | — | 2007-05-01 |
| Completed | A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer Small Cell Lung Cancer | Phase 2 | 2006-04-01 |
| Terminated | A Correlative Study for Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer Breast Cancer | — | 2005-09-01 |
| Terminated | Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple Myeloma Multiple Myeloma | Phase 2 | 2005-06-01 |
| Terminated | Rituximab and Gemcitabine for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Lymphoma, B-Cell | Phase 2 | 2005-04-01 |
| Terminated | PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast Cancer Breast Cancer | Phase 1 / Phase 2 | 2005-01-01 |
| Terminated | Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer Small Cell Lung Cancer | Phase 2 | 2005-01-01 |
| Terminated | Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer Metastatic Breast Cancer | Phase 2 | 2004-03-01 |
| Completed | Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast Cancer Metastatic Breast Cancer | Phase 2 | 2004-03-01 |
| Terminated | Docetaxel and Capecitabine for First Line Treatment of Metastatic Squamous Cell Carcinoma of the Head & Neck Head and Neck Cancer | Phase 2 | 2004-03-01 |